Atsuko Ikenouchi

3.0k citations

136 papers · 2.3k indexed · h-index 27

Cellular and Molecular Neuroscience top 2%
Biological Psychiatry top 0.5%
Psychiatry and Mental health top 2%
Cognitive Neuroscience top 5%
Behavioral Neuroscience top 1%

Co-authors: Reiji Yoshimura Jun Nakamura Hikaru Hori Nobuhisa Ueda Wakako Umene‐Nakano Asuka Katsuki Kenji Hayashi Masae Mitoma
Topics: Tryptophan and brain disorders (26 papers)Treatment of Major Depression (23 papers)Nerve injury and regeneration (22 papers)
Cited by: Biological Psychiatry Behavioral Neuroscience Developmental Neuroscience
Journals: SHILAP Revista de lepidopterologíaPLoS ONE Scientific Reports
Partner nations: Japan United States Vietnam

In The Last Decade

Atsuko Ikenouchi

128 papers receiving 2.2k citations

Peers

Countries citing papers authored by Atsuko Ikenouchi

Since Specialization

Citations

This map shows the geographic impact of Atsuko Ikenouchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuko Ikenouchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuko Ikenouchi more than expected).

Fields of papers citing papers by Atsuko Ikenouchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuko Ikenouchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuko Ikenouchi. The network helps show where Atsuko Ikenouchi may publish in the future.

Co-authorship network of co-authors of Atsuko Ikenouchi

This figure shows the co-authorship network connecting the top 25 collaborators of Atsuko Ikenouchi. A scholar is included among the top collaborators of Atsuko Ikenouchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsuko Ikenouchi. Atsuko Ikenouchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serum Extracellular Vesicle-Derived hsa-miR-2277-3p and hsa-miR-6813-3p Are Potential Biomarkers for Major Depression: A Preliminary Study 2023 ·International Journal of Molecular Sciences ·(unknown),Hiroto Izumi,(unknown),Atsuko Ikenouchi,Yasuo Morimoto,Seichi Horie,Reiji Yoshimura	6
2	The effects of telecommuting and family cohabiting situation on psychological distress in Japanese workers during the COVID-19 pandemic: A cross-sectional study 2023 ·Journal of Occupational Health ·Atsuko Ikenouchi,Yoshihisa Fujino,(unknown),Kosuke Mafune,Hajime Ando,Tomohisa Nagata,Seiichiro Tateishi,Reiji Yoshimura,Mayumi Tsuji,(unknown),Akira Ogami,Ayako Hino,Hisashi Eguchi,Keiji Muramatsu,Koji Mori,(unknown),(unknown),Shinya Matsuda,Tomohiro Ishimaru,(unknown)	1
3	Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms 2023 ·Frontiers in Psychiatry ·(unknown),(unknown),Keita Watanabe,(unknown),(unknown),(unknown),Atsuko Ikenouchi,Shingo Kakeda,Reiji Yoshimura	2
4	Associations of Serum Cytokines, Growth Factors, and High-Sensitivity C-Reactive Protein Levels in Patients with Major Depression with and without Type 2 Diabetes Mellitus: An Explanatory Investigation 2022 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),(unknown),(unknown),Atsuko Ikenouchi,Yuichi Honma,Masaru Harada,Reiji Yoshimura	5
5	Effects of Paroxetine on Plasma Levels of Vascular Endothelial Growth Factor in Patients with Major Depression. 2022 ·PubMed ·Reiji Yoshimura,Naomichi Okamoto,Atsuko Ikenouchi	2
6	Hippocampal Volume and Plasma Brain-Derived Neurotrophic Factor Levels in Patients With Depression and Healthy Controls 2022 ·Frontiers in Molecular Neuroscience ·(unknown),Keita Watanabe,(unknown),(unknown),(unknown),Ryohei Igata,Yuki Konishi,Atsuko Ikenouchi,Shingo Kakeda,Reiji Yoshimura	11
7	Cerebral Amyloid Angiopathy With a Hypomanic Episode Treated With Valproic Acid 2021 ·Cureus ·(unknown),Atsuko Ikenouchi,(unknown),(unknown),Reiji Yoshimura	1
8	Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram 2021 ·SHILAP Revista de lepidopterología ·Reiji Yoshimura,(unknown),Ryohei Igata,Atsuko Ikenouchi	0
9	A Young Japanese Patient with Spinocerebellar Ataxia Type 3 Presenting Depressive State with Cenesthopathy and Delusion: a Case Report 2021 ·The Cerebellum ·(unknown),Atsuko Ikenouchi,Satoru Ide,Yu Hashimoto,Reiji Yoshimura	1
10	Anti-Müllerian hormone as a possible predictor of fecundability in subfertile women over 38 years: a retrospective cohort study 2014 ·Gynecological Endocrinology ·(unknown),Akira Iwase,Atsuko Ikenouchi,Maki Goto,Tatsuo Nakahara,Tomoko Nakamura,Mika Kondo,Satoko Osuka,Masahiko Mori,(unknown),Fumitaka Kikkawa	6
11	Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients 2014 ·Annals of General Psychiatry ·Reiji Yoshimura,Taro Kishi,Hikaru Hori,Kiyokazu Atake,Asuka Katsuki,(unknown),Atsuko Ikenouchi,Nakao Iwata,Jun Nakamura	21
12	Plasma levels of interleukin‐6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder 2013 ·Human Psychopharmacology Clinical and Experimental ·Reiji Yoshimura,Hikaru Hori,Atsuko Ikenouchi,Wakako Umene‐Nakano,Asuka Katsuki,Kiyokazu Atake,Jun Nakamura	54
13	One-year follow-up of serum antimüllerian hormone levels in patients with cystectomy: are different sequential changes due to different mechanisms causing damage to the ovarian reserve? 2013 ·Fertility and Sterility ·Atsuko Ikenouchi,Akira Iwase,Maki Goto,Tatsuo Nakahara,Tomoko Nakamura,Mika Kondo,Satoko Osuka,Masahiko Mori,(unknown),Fumitaka Kikkawa	84
14	[Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder]. 2010 ·PubMed ·Reiji Yoshimura,Atsuko Ikenouchi,Hikaru Hori,Wakako Umene‐Nakano,Kenji Hayashi,Asuka Katsuki,Nobuhisa Ueda,Jun Nakamura	9
15	Inducible Nitric Oxide Synthase Downmodulates Contact Hypersensitivity by Suppressing Dendritic Cell Migration and Survival 2009 ·Journal of Investigative Dermatology ·Kazunari Sugita,Kenji Kabashima,Ryutaro Yoshiki,Atsuko Ikenouchi,Masato Tsutsui,Jun Nakamura,Nobuyuki Yanagihara,Y. Tokura	17
16	Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients 2009 ·Human Psychopharmacology Clinical and Experimental ·Reiji Yoshimura,Wakako Umene‐Nakano,Akihito Suzuki,Nobuhisa Ueda,Kyoko Miyamoto,Atsuko Ikenouchi,Hikaru Hori,Koichi Otani,Jun Nakamura	21
17	Opposite effects of milnacipran, a serotonin norepinephrine reuptake inhibitor, on the levels of nitric oxide and brain-derived neurotrophic factor in mouse brain cortex 2009 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Atsuko Ikenouchi,Yumiko Toyohira,Reiji Yoshimura,Susumu Ueno,Masato Tsutsui,Jun Nakamura,Nobuyuki Yanagihara	12
18	Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients 2007 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Reiji Yoshimura,Masae Mitoma,Atsuko Ikenouchi,Hikaru Hori,Tatsuya Okamoto,(unknown),Nobuhisa Ueda,Jun Nakamura	157
19	Isolation and identification of 2α,25-dihydroxyvitamin D3, a new metabolite from Pseudonocardia autotrophica 100U-19 cells incubated with Vitamin D3 2006 ·Steroids ·Koji Takeda,(unknown),Atsuko Ikenouchi,(unknown),(unknown),Masato Shimizu	6
20	Plasma levels of brain derived-neurotrophic factor and catecholamine metabolites are increased during active phase of psychotic symptoms in CNS lupus: A case report 2006 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Atsuko Ikenouchi,Reiji Yoshimura,(unknown),Kensuke Utsunomiya,Masae Mitoma,Jun Nakamura	12

About Atsuko Ikenouchi

Atsuko Ikenouchi is a scholar working on Biological Psychiatry, Behavioral Neuroscience and Developmental Neuroscience, having authored 136 papers that have together received 2.3k indexed citations. Recurring topics across this work include Tryptophan and brain disorders (26 papers), Treatment of Major Depression (23 papers) and Nerve injury and regeneration (22 papers). The work is most often cited by research in Biological Psychiatry (615 citations), Behavioral Neuroscience (422 citations) and Developmental Neuroscience (284 citations). Atsuko Ikenouchi has collaborated with scholars based in Japan, United States and Vietnam. Frequent co-authors include Reiji Yoshimura, Jun Nakamura, Hikaru Hori, Nobuhisa Ueda, Wakako Umene‐Nakano, Asuka Katsuki, Kenji Hayashi, Masae Mitoma, Kiyokazu Atake and Tatsuya Okamoto. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact